CHAPTER 215 Swan-Ganz (Pulmonary Artery) Catheterization
For over 30 years the use of the balloon-flotation, flow-directed pulmonary artery (PA) thermodilution (Swan-Ganz) catheter has symbolized modern care of the critically ill patient. However, in the past 10 years several studies have found that the PA catheter does not reduce morbidity or mortality. These studies are summarized in the Cochrane Collaborative paper that states “even though the trials measured numbers of deaths in each group at different points of time, all reported that there were no differences between patients who did and did not have a PA catheter inserted” (Harvey and colleagues, 2006). Another meta-analysis in the Journal of the American Medical Association similarly showed that “the use of PA catheter neither increased overall mortality in the hospital nor conferred benefit” (Shah and colleagues, 2005).
Alternatively, early goal-directed therapy (EGDT, which uses a regular central line and monitors central venous pressure [CVP] and central venous oxygen saturation [SCVO2]) in patients with septic shock demonstrated impressive survival rates in a landmark study in 2001 (Rivers and colleagues, 2001). The standard therapy group had an in-hospital mortality rate of 46.5%, compared with 30.5% for those assigned to EGDT. Protocol patients were resuscitated to a CVP of 8 to 12 mm Hg and a mean arterial pressure of 65 mm Hg. If at this point their SCVO2 was below 70%, packed red cells were transfused to a hematocrit of 30% and dobutamine added, if necessary, until their SCVO2 normalized to 70%. If still not there, mean arterial pressure was titrated to 65 mm Hg with either norepinephrine or dopamine (Rivers and colleagues, 2001). Subsequent trials have validated these results with similar or better findings (Otero and colleagues, 2006). As a result, many intensive care units have moved away from the PA catheter and are using less invasive methods such as central lines for CVP monitoring and echocardiograms to evaluate cardiac function (see Chapter 90, Echocardiography, and Chapter 225, Emergency Department, Hospitalist, and Office Ultrasonography [Clinical Ultrasonography]). There is even exciting new technology available that provides continuous measurement of cardiac output using just a radial arterial line. That said, PA catheters still have a major role in critical care. Pinsky and Vincent (2005) proposed an algorithm for use of PA catheters (Fig. 215-1); their criteria for initiation of the protocol “would be ongoing circulatory shock despite initial fluid resuscitation efforts or, in the setting of normotension, persistent tachycardia, metabolic acidosis, lactic acidosis, altered mental status, or decreased urine output, since all these are signs or indirect markers of inadequate tissue perfusion.” Further study is needed to compare PA catheter-derived outcomes with those using a mere central line. As of this writing, PA catheters still remain an important, although less frequently used, assessment tool in critical care.
Indications
Monitoring
Contraindications
Contraindications are the same as those for central venous catheterization (see Chapter 211, Central Venous Catheter Insertion), plus the following relative contraindications:
Equipment
Preprocedure Patient Preparation
Because PA catheterization is usually an emergency procedure, written informed consent cannot always be obtained. However, explain the indications, risks, benefits, and any available alternatives to the patient and the family, if possible. If the consent is implied, it should be documented. If time allows, the patient or family should sign for informed consent. Venous access may be established by the procedure outlined in Chapter 211, Central Venous Catheter Insertion. As delineated in Chapter 216, Temporary Pacing, catheterization of the right internal jugular vein provides the most direct access to the right atrium and ventricle, but its use may restrict patient mobility. The broad curve of the left subclavian vein may make it more difficult to traverse than the right internal jugular, but it is a reasonable second choice. The left internal jugular and right subclavian veins are acceptable alternatives. The femoral vein is another option, but it is infrequently used and often necessitates the use of fluoroscopy to properly advance the catheter. The external jugular, axillary, and basilic veins are additional options, but are also often difficult to traverse.